Shares of C3.ai Inc. AI slipped 6.06% to $22.03 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 1.76% to 5,849.72 and Dow ...

Jaipur, Mar 3 (PTI) India on Monday said there should be a new global platform that will accelerate the adoption of a ...

C3.ai, Inc. (AI) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...

Manohar Lal, Union Minister for Housing and Urban Affairs, on Monday announced the Cities Coalition for Circularity (C-3), a ...

C3.ai (NYSE:AI – Free Report) had its price objective lowered by DA Davidson from $40.00 to $25.00 in a research report sent to investors on Thursday,Benzinga reports. The brokerage currently has a ...

Needham & Company LLC reiterated their hold rating on shares of C3.ai (NYSE:AI – Free Report) in a research note issued to investors on Thursday morning,Benzinga reports. Other research analysts have ...

Tmall Magic Screen C3 Air projector debuts with 1080P resolution, a built-in clock, a 360° adjustable stand, and an SSD2381 chip.

Feb. 27 at approximately 6:35 p.m., members of the Springfield Police C3 Units seized a loaded firearm and arrested ...

About Fabhalta® (iptacopan) Fabhalta (iptacopan) is an oral, Factor B inhibitor of the alternative complement pathway 6-7.

Shares of C3.ai Inc. AI slipped 1.80% to $23.45 Friday, on what proved to be an all-around positive trading session for the ...

A new study highlights the importance of normal serology in reducing severe and renal flares in systemic lupus erythematosus ...

Apple's new 'e' series smartphone could be a regular thing: new iPhone 16e would be followed up by iPhone 17e in 2026 with in ...